GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Interest Coverage

Optigenex (Optigenex) Interest Coverage : N/A (As of Jun. 2008)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Optigenex's Operating Income for the three months ended in Jun. 2008 was $-0.20 Mil. Optigenex's Interest Expense for the three months ended in Jun. 2008 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Optigenex's Interest Coverage or its related term are showing as below:


OPGX's Interest Coverage is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 13.21
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Optigenex Interest Coverage Historical Data

The historical data trend for Optigenex's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Optigenex Interest Coverage Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
Interest Coverage
No Debt N/A N/A N/A

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Optigenex's Interest Coverage

For the Diagnostics & Research subindustry, Optigenex's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optigenex's Interest Coverage Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Optigenex's Interest Coverage falls into.



Optigenex Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Optigenex's Interest Coverage for the fiscal year that ended in Dec. 2007 is calculated as

Here, for the fiscal year that ended in Dec. 2007, Optigenex's Interest Expense was $0.00 Mil. Its Operating Income was $-1.39 Mil. And its Long-Term Debt & Capital Lease Obligation was $4.43 Mil.

GuruFocus does not calculate Optigenex's interest coverage with the available data.

Optigenex's Interest Coverage for the quarter that ended in Jun. 2008 is calculated as

Here, for the three months ended in Jun. 2008, Optigenex's Interest Expense was $0.00 Mil. Its Operating Income was $-0.20 Mil. And its Long-Term Debt & Capital Lease Obligation was $3.24 Mil.

GuruFocus does not calculate Optigenex's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Optigenex  (OTCPK:OPGX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Optigenex Interest Coverage Related Terms

Thank you for viewing the detailed overview of Optigenex's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines